<DOC>
	<DOCNO>NCT01436825</DOCNO>
	<brief_summary>OPTIMS non interventional validation study calculator develop Bayer clinician 's use prophylactic treatment factor VIII patient severe moderate Haemophilia A severe clinical profile . The study take place single visit , time patient enrollment study</brief_summary>
	<brief_title>Validation Study cOmputer Pharmacokinetic Tool assIst Follow Care haeMophilia A Patients</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Patient severe haemophilia A defined residual factor VIII activity &lt; 1 % Patient moderate haemophilia A ( residual factor VIII activity &gt; 1 % &lt; 5 % ) severe clinical profile Patient treat prevention plasma recombinant factor VIII least 6 month Patient whose inclusion visit perform routine visit include measurement plasma residual factor VIII : c level In medical file ( retrospective data ) pharmacokinetic parameter available obtain PK analysis factor VIII level perform anti haemophilic factor one use inclusion day Patients haemophilia B</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Haemophilia A</keyword>
	<keyword>Factor VIII</keyword>
	<keyword>Pharmacokinetic</keyword>
	<keyword>Computer Tool validation</keyword>
</DOC>